At the molecular level, targeting HMGB1 inhibits Siah-2-induced HIPK2 ubiquitination and upregulates HIPK2 protein expression, suggesting that targeting HMGB1 could suppress HCC progression via HIPK2 activation [68]. The gene discussed is HIPK2; the disease is hepatocellular carcinoma.